Literature DB >> 2509305

Bacterial vaginosis is not a simple ecological disorder.

B Fredricsson1, K Englund, L Weintraub, A Olund, C E Nord.   

Abstract

Eighty-four patients with bacterial vaginosis were examined in an open randomized trial, the aim of which was to define clinical results and the microbiological panorama after topical treatment for 1 week with either an acetic acid jelly (A), an estrogen cream (B), a fermented milk product (C) or metronidazole (D). After exclusion because of chlamydia infection (15 cases) or for other reasons, 61 cases remained for complete evaluation 4 weeks after the start of treatment. Clinical cure was obtained in 3 cases out of 17 on regimen A, in 1 out of 16 on regimen B, in 1 of 14 on regimen C, and in 13 out of 14 on regimen D. The patients were conclusively either symptomless or symptomatic when examined on 113 occasions. Statistically significant reduction after treatment resulting in relief of symptoms was observed in the numbers of corynebacteria and anaerobic cocci, whereas lactobacilli increased in numbers. The instillation of high numbers of Lactobacillus acidophilus (C) into the vagina cured only 1 patient and did not influence the predominance of lactobacilli in the vagina at the follow-up examination. The difference in microbiological profile of women in symptomatic and asymptomatic conditions becomes still more apparent when the results of the present and previously published studies on the subject by the present group of investigators are combined. The symptomatic woman is significantly more often harboring corynebacteria, Gardnerella vaginalis, peptostreptococci, peptococci, eubacteria and Bacteroides species. Lactobacilli are significantly reduced in numbers. However, only 51% of our previously symptomatic, but now symptomless women show predominant growth of lactobacilli, which is less than expected for healthy women.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509305     DOI: 10.1159/000293556

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  11 in total

1.  A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis.

Authors:  Jose A Simoes; Luis G Bahamondes; Rodrigo P S Camargo; Valeria M N Alves; Lourens J D Zaneveld; Donald P Waller; Jill Schwartz; Marianne M Callahan; Christine K Mauck
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

2.  Sustained delivery of commensal bacteria from pod-intravaginal rings.

Authors:  Manjula Gunawardana; Madeline Mullen; Jennifer Yoo; Paul Webster; John A Moss; Marc M Baum
Journal:  Antimicrob Agents Chemother       Date:  2014-02-03       Impact factor: 5.191

3.  Non-antibiotic treatment of bacterial vaginosis-a systematic review.

Authors:  Fiona Damaris Tidbury; Anita Langhart; Susanna Weidlinger; Petra Stute
Journal:  Arch Gynecol Obstet       Date:  2020-10-06       Impact factor: 2.344

4.  Vaginal microbiological flora and sexually transmitted diseases in women with recurrent or current vulvovaginal candidiasis.

Authors:  B Zdolsek; D Hellberg; G Fröman; S Nilsson; P A Mårdh
Journal:  Infection       Date:  1995 Mar-Apr       Impact factor: 3.553

Review 5.  The aetiology of bacterial vaginosis.

Authors:  Y Turovskiy; K Sutyak Noll; M L Chikindas
Journal:  J Appl Microbiol       Date:  2011-03-14       Impact factor: 3.772

Review 6.  Gardnerella vaginalis: characteristics, clinical considerations, and controversies.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

7.  Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: a randomised clinical trial.

Authors:  A J Boeke; J H Dekker; J T van Eijk; P J Kostense; P D Bezemer
Journal:  Genitourin Med       Date:  1993-10

8.  Association Analysis on Recurrence of Bacterial Vaginosis Revealed Microbes and Clinical Variables Important for Treatment Outcome.

Authors:  Bingbing Xiao; Chunyan Wu; Wenfeng Song; Xiaoxi Niu; Nan Qin; Zhaohui Liu; Qian Xu
Journal:  Front Cell Infect Microbiol       Date:  2019-06-11       Impact factor: 5.293

9.  Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis.

Authors:  Lindsay Armstrong-Buisseret; Clare Brittain; Miruna David; Gillian Dean; Frances Griffiths; Trish Hepburn; Louise Jackson; Joe Kai; Alan Montgomery; Tracy Roberts; Sukhwinder Thandi; Jonathan D C Ross
Journal:  Trials       Date:  2019-11-27       Impact factor: 2.279

10.  Vaginal microbiota and the use of probiotics.

Authors:  Sarah Cribby; Michelle Taylor; Gregor Reid
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.